Authors


Heather A. Berlin, PhD, MPH

Latest:

Understanding the Differences Between Impulsivity and Compulsivity

A review of targeted treatment strategies for symptom domains when impulsivity and compulsivity become dysfunctional.


Heidi Anne Duerr, MPH

Latest:

Preparing Patients for the Fourth of July Holiday

Prepare your patients for the Fourth of July with expert tips from Roger Rivera, FNP, PMHNP, DNP, on managing risky behaviors, adherence distractions, PTSD-related triggers, and sensory overload during the holiday.


Heidi Moawad, MD

Latest:

Key Takeaways and the Future of Narcolepsy Treatment

An expert panel concludes the discussion by reviewing factors to consider when diagnosing and treating narcolepsy.


Heidi S. Resnick, PhD

Latest:

Rape-Related PTSD: Issues and Interventions

Rape is a crime that is defined as an unwanted sexual act that results in oral, vaginal, or anal penetration. Generally speaking, there are 2 major types of rape. Forcible rape involves unwanted sexual penetration obtained by the use of force or threat of force. Drug- or alcohol-facilitated rape occurs when the victim is passed out or highly intoxicated because of voluntary or involuntary consumption of alcohol or drugs. Rape can happen to boys and men as well as to girls and women but this article will focus primarily on women.


Helen Christensen, PhD

Latest:

Apps for Suicide Prevention: What the Research Says

A review of smartphone tools for suicide prevention and recommendations for clinicians.


Helen D. Pratt, PhD

Latest:

Predicting, Assessing, and Treating Self-Harm in Adolescents

The authors differentiate between 3 types of deliberate self-harm: nonsuicidal self-injury, culturally sanctioned body modifications (tattooing or body piercing), and unintentional or accidental injury.


Helen H. Kyomen, MD, MS

Latest:

The Science, Ethics, and Art of Disclosing a Dementia Diagnosis

How can you communicate the diagnosis in a way that relieves suffering and helps patients and their caregivers prepare for the future?


Helen Lavretsky, MD, MS

Latest:

Polypharmacy in Older Adults

Clinicians should carefully weigh the risks and benefits of each prescribed medication for an older adult with neuropsychiatric diseases and periodically review all prescribed medications. Learn more here.


Helen M. Farrell, MD

Latest:

Introduction: Meeting Our Personal and Professional Goals

By building a practice model that we enjoy, it enhances our ability to “cure sometimes, treat often, and comfort always.”


Helen M. Pettinati, PhD

Latest:

Advances and Challenges in Treating Alcohol Dependence With Pharmacotherapy

Alcoholism is a chronic and serious disorder with often devastating consequences. One out of three families in the United States is negatively impacted by a family member's excessive drinking and painful drinking-related problems.


Helen Montague Foster, MD

Latest:

The Patient-Physician Bond

During my medical training in the early 1980s, I attended a Grand Rounds on health care reform. Sleep-deprived physicians-in-training are easily conditioned to snooze upright in their auditorium seats, and economics is not an interest of choice for me, but when the speaker told us that there would be no solution to rising health care costs except to fracture the bond between patient and doctor, I found myself engaging in nightmarish fantasies that in subsequent decades have come true.


Helen Riess, MD

Latest:

Risk Management for the Supervising Psychiatrist

The need for expert supervision of residents and other health professionals by psychiatrists is growing as a result of the increased demand for accountability by third parties and the expanded number of clinical specialists seeking supervision in psychiatry. The Accreditation Council for Graduate Medical Education has placed professional competency of graduating residents in the national spotlight, and insurers are increasingly scrutinizing patient care provided by trainees and oversight provided by their supervisors.


Henry David Abraham, MD

Latest:

Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments (2 volumes)

The use of psychedelic plants and drugs in psychiatric medicine has been a promise for more than half a century, suppressed by a draconian legal response to the epidemic of drug abuse in the 1960s. This 2-volume work seeks to reverse the suppression of scientific inquiry in this field by bringing together a comprehensive airing of the topic.


Henry Pinsker, MD

Latest:

The Supportive Component of Psychotherapy

In view of the fact that support is an important aspect of all models of psychotherapy, it is remarkable that beginning practitioners are not taught how to be supportive. Only limited attention has been paid to discussion of the principles underlying supportive interactions. It seems to be taken for granted that good sense, kindness, innate empathy and life experience will enable psychotherapists-and physicians in general-to meet their patients' needs for support by communicating interest, liking and understanding. Just as the literature on psychoanalysis is a source for much of what we know about the expressive component of therapy, the limited literature on supportive psychotherapy is a source for ideas pertinent to the supportive component.


Henry R. Kranzler, MD

Latest:

Topiramate and Heavy Drinking: Implications for Personalized Medicine

Very few heavy drinkers receive treatment and fewer still are prescribed medications with demonstrated efficacy. Here, a summary of current research, key takeaways, and highlights from a study on topiramate treatment for heavy drinkers by the lead author of that study.


Henry W. Dove, MD

Latest:

Challenges and Obstacles in Treating Mentally Ill Black Patients

As the United States becomes more culturally, racially, and ethnically diverse, psychiatry will be faced with the need to treat more diverse populations. This article focuses on challenges and obstacles encountered when treating black patients with mental illness.


Herb Ochitill, MD

Latest:

Progress and Promise: Research and Education in Psychosomatic Medicine

Practitioners understand the wholeness and unity of their patients. Instead of being considered isolated organ systems or enzyme cycles, patients are understood as coherent entities composed of coordinated and interrelated processes and systems. This fundamental understanding guidesinvestigative and clinical care approaches in psychosomatic medicine.


Herbert D. Kleber, MD

Latest:

The Lasting Effects of Marijuana Use

There is increasing evidence that individuals who try marijuana during their early teenage years are affected neurologically for a decade or more at least until one's 20s and perhaps even longer. More in this video.


Herbert Hendin, MD

Latest:

Commentary: The Case Against Physician-Assisted Suicide: For the Right to End-of-Life Care

Euthanasia is a word coined from Greek in the 17th century to refer to an easy, painless, happy death. In modern times, however, it has come to mean a physician's causing a patient's death by injection of a lethal dose of medication. In physician-assisted suicide, the physician prescribes the lethal dose, knowing the patient intends to end their life.


Herbert Scheier, MD

Latest:

Global Findings in Developmental Psychopathology Presented at ESCAP

A greater understanding of how the brain works, including the effect of environment on it development, has led to advances in diagnosing and treating psychopathology. The latest findings will be presented at an international meeting, along with a discussion of how much work is to be done and the great need for qualified child psychiatrists, especially in developing countries.


Herbert Y. Meltzer, MD

Latest:

Refractory Psychosis: Treatment Options and Strategies

Psychosis is one of the key dimensions of schizophrenia, bipolar disorder, and psychotic depression. Clinicians are familiar with patients whose psychosis improves dramatically with antipsychotic treatment; however, these patients may be left with cognitive impairment, negative mood symptoms, or suicidal symptoms, as well as impaired work and social functioning.


Herman M. Van Praag, MD, PhD

Latest:

Enlightenment and Dimmed Enlightenment

Psychiatrists cannot, with impunity, disregard an important domain of man’s personality makeup. He ought to remain a searcher of the soul at large.


Hilit Kletter, PhD

Latest:

Treatment of Traumatic Stress Disorder in Children and Adolescents

The role of prevention of trauma and prevention of functional impairment after trauma is paramount, because this may disrupt the accumulated physiological and psychological effect of stressors in the individual.


Hind T. Hatoum, PhD

Latest:

Light Treatment for Nonseasonal Depression

Daniel F. Kripke, M.D. has studied the relationship between biological rhythms and depression since the early 1970s. He states that seasonal responses in many mammals are controlled by the photoperiod. Therefore, it seemed that depression might be analogous to winter responses and that light might be an effective treatment.


Hinemoa Elder, MBChB, FRANZCP, PhD

Latest:

Advances in Psychiatry: Understanding Indigenous Cultures

Epidemiological research has shown that the Māori people of New Zealand are approximately twice as likely to have serious psychiatric illness compared with non-Māori. Here, a child and adolescent psychiatrist describes her work in Aotearoa, New Zealand.


Hiroto Ito, PhD

Latest:

Effect of Gender Differences on the Cardiovascular System in Patients With Mental Disorders

Tricyclic antidepressants and antipsychotics are known to prolong cardiac repolarization and induce QTC interval prolongation, possibly putting patients with mental disorders at higher risk of cardiovascular diseases. The mechanism of gender difference in vulnerability for cardiovascular diseases is still unclear, but the role of hormones is one of possible explanatory factors.


Hochang Benjamin Lee, MD

Latest:

Collaborative Care Meets Hospital Medicine: Proactive Consultation-Liaison Psychiatry

Mental illness accounts for a third of all years lived with disability and is associated with twice the relative risk of all-cause mortality. An estimated 8 million deaths are attributable to mental disorders every year, with two-thirds due to comorbid medical illness.


Holly A. Garriock, PhD

Latest:

The μ-Opioid System and Antidepressant Response

This article discusses the role of µ-opioid receptors (MORs) in antidepressant treatment and major depressive disorder (MDD). Specifically, it focuses on how the endogenous opioid system affects response to pharmaceuticals.


Holly Briklin, MD

Latest:

The Adolescent Brain

An expert Q&A with Laurence Steinberg, PhD. His newest book offers insights into the malleable adolescent brain and provides guidance to parents hoping to better understand adolescents.


Holly Peek, MD, MPH

Latest:

Technology in Psychiatry: Year in Review

As technology continues to expand exponentially, so does our potential to harness these technological capabilities to expand the field of psychiatry. At Psychiatric Times this year, we highlighted a range of topics on these advancements.

© 2024 MJH Life Sciences

All rights reserved.